“Generic Drugs Market - Global Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth and Forecast, 2023-2028” provides a deep and thorough evaluation of the global generic drugs market. Generic drugs refer to pharmaceutical medicines that contain the same ingredient as an existing branded drug. They are identical in terms of dosage, administration, quality and characteristics to the original drug. Generic drugs are commonly available in liquid syrups, tablets, capsules, inhalers, drops and injections. As compared to the branded drugs, they are easy to obtain and assist the patients in staying on course due to their cost-effectiveness.
The global generic drugs market is primarily being driven by the increasing prevalence of chronic diseases, such as asthma and diabetes, along with the rising geriatric population. Furthermore, various technological advancements, such as the advent of 3D printing technologies, which enable the drug manufacturers to customize the size, shape and texture of drugs for enhanced efficacy and cost-effectiveness, are contributing to the market growth.
Beginning with a global overview, the report explores the dynamics that have a strong influence on the generic drugs market and can also impact its future growth. Taking 2022 as the base year, the report covers the historical market scenario from 2017-2022 and provides forecasts till 2028. This includes the study of value and volume trends and pricing history. Growth-inducing factors, market restraints and recent developments have also been analysed in the report in order to provide deeper knowledge about the industry. On a regional basis, the report examines the generic drugs market in North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. For each of these regions, the report studies the generic drugs market in detail for the latest trends, outlook and opportunities.
The report analyses the competitive structure of the generic drugs Industry and provides the profiles of major players operating in the market. The price margins for the products, along with the various success and risk factors for manufacturers, have also been covered in the report. Moreover, in order to determine market attractiveness, the report analyses the generic drugs Industry along the parameters of Porter’s Five Forces model. This model examines the degree of competition in the generic drugs Industry by analysing the threat posed by new entrants and substitutes and the bargaining power of suppliers and buyers. SWOT analysis of the market has also been presented in the report, which highlights the strengths, weaknesses, opportunities and threats pertaining to the generic drugs Industry. Furthermore, the value chain analysis of the generic drugs Industry has also been covered in the report. This comprises all the activities in the value chain, such as the procurement of various raw materials, manufacturing, sales and distribution.
Key Segments and Highlights of the Global Generic Drugs Market
The report is a result of exhaustive primary and secondary research undertaken by analysts having years of experience in the generic drugs Industry. All the qualitative and quantitative aspects of the industry have been covered and the collected data has been analysed and presented in the form of easily comprehensible charts, graphs and tables.
1 Introduction
1.1 Research Objectives
1.2 Stakeholders
1.3 Scope of the Report
1.4 Assumptions and Limitations
2. Research Methodology
2.1. Data Collection
2.1.1 Primary Sources
2.1.2 Secondary Sources
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Data Validation
3. Executive Summary
4. Global Generic Drugs Market
4.1 Industry Overview
4.2 Key Industry Developments
4.3 Market Trends
4.3.1 Key Market Indicators
4.3.2 Historical Market Trends
4.3.3 Impact of COVID-19
4.3.4 Market Forecast
4.4 Price Analysis
4.4.1 Key Price Indicators
4.4.2 Pricing Structure
4.4.3 Historical Price Trends
4.4.4 Price Forecast
4.5 Market Breakup by Region
4.6 Market Breakup by Type
4.7 Market Breakup by End-Use
5. Global Generic Drugs Market: Value Chain Analysis
5.1 Overview
5.2 Research and Development
5.3 Raw Material Suppliers
5.4 Inbound Logistics
5.5 Production
5.6 Marketing
5.7 Outbound Logistics
5.8 Consumers
6. Global Generic Drugs Market: SWOT Analysis
6.1 Overview
6.2 Strengths
6.3 Weaknesses
6.4 Opportunities
6.5 Threats
7. Global Generic Drugs Market: Porter’s Five Forces Analysis
7.1 Overview
7.2 Threat of New Entrants
7.3 Threat of Substitutes
7.4 Bargaining Power of Buyers
7.5 Bargaining Power of Suppliers
7.6 Intensity of Rivalry
8. Competitive Landscape
8.1 Market Structure
8.2 Key Players
8.3 Key Success Factors
9. Performance by Region
9.1 North America
9.1.1 Overview
9.1.2 Market Trends
9.1.3 Market Segmentation
9.1.4 Market Forecast
9.2 Europe
9.2.1 Overview
9.2.2 Market Trends
9.2.3 Market Segmentation
9.2.4 Market Forecast
9.3 Asia Pacific
9.3.1 Overview
9.3.2 Market Trends
9.3.3 Market Segmentation
9.3.4 Market Forecast
9.4 Latin America
9.4.1 Overview
9.4.2 Market Trends
9.4.3 Market Segmentation
9.4.4 Market Forecast
9.5 Middle East and Africa
9.5.1 Overview
9.5.2 Market Trends
9.5.3 Market Segmentation
9.5.4 Market Forecast
10 Key Player Profiles
List of Figures
Figure 1: Global: Generic Drugs Market, 2017-2022
Figure 2: Global: Generic Drugs Market Forecast, 2023-2028
Figure 3: Global: Generic Drugs Market: Price Trends, 2017-2022
Figure 4: Global: Generic Drugs Market Forecast: Price Trends, 2023-2028
Figure 5: Global: Generic Drugs Market: Breakup by Region, 2022
Figure 6: Global: Generic Drugs Market: Breakup by Type, 2022
Figure 7: Global: Generic Drugs Market: Breakup by End Use, 2022
Figure 8: Global: Generic Drugs Industry: Value Chain Analysis
Figure 9: Global: Generic Drugs Industry: SWOT Analysis
Figure 10: Global: Generic Drugs Industry: Porter’s Five Forces Analysis
Figure 11: Global: Generic Drugs Market: Key Players
Figure 12: North America: Generic Drugs Market, 2017-2022
Figure 13: North America: Generic Drugs Market: Breakup by Segment, 2022
Figure 14: North America: Generic Drugs Market Forecast, 2023-2028
Figure 15: Europe: Generic Drugs Market, 2017-2022
Figure 16: Europe: Generic Drugs Market: Breakup by Segment, 2022
Figure 17: Europe: Generic Drugs Market Forecast, 2023-2028
Figure 18: Asia Pacific: Generic Drugs Market, 2017-2022
Figure 19: Asia Pacific: Generic Drugs Market: Breakup by Segment, 2022
Figure 20: Asia Pacific: Generic Drugs Market Forecast, 2023-2028
Figure 21: Latin America: Generic Drugs Market, 2017-2022
Figure 22: Latin America: Generic Drugs Market: Breakup by Segment, 2022
Figure 23: Latin America: Generic Drugs Market Forecast, 2023-2028
Figure 24: Middle East and Africa: Generic Drugs Market, 2017-2022
Figure 25: Middle East and Africa: Generic Drugs Market: Breakup by Segment, 2022
Figure 26: Middle East and Africa: Generic Drugs Market Forecast, 2023-2028
List of Tables
Table 1: Global: Generic Drugs Industry: Market Summary
Table 2: Global: Generic Drugs Industry: Market Overview, 2022 and 2028
Table 3: Global: Generic Drugs Industry: Market Structure
Table 4: Global: Generic Drugs Market: Market by Region, 2023-2028
Personalize this research
Triangulate with your own data
Get data as per your format and definition
Gain a deeper dive on a specific application, geography, customer or competitor
Any level of personalization
US: +1-213-316-7435
Uk: +44-702-409-7740
sales@syndicatedanalytics.com
The GCC Weight Management Market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. The market is projected to register a CAGR of X% during 2023-2028, reaching US$ XX Billion by 2028.
Read More The GCC orthopedic braces and supports market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe GCC generic drug market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe GCC telemedicine market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe UAE mhealth market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe Saudi Arabia health insurance market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read More+1-213-316-7435
us.sales@syndicatedanalytics.com
+44-702-409-7740
uk.sales@syndicatedanalytics.com
© Copyright Syndicated Analytics 2023.